Featured Articles and Interviews
Aug 14, 2025
Top 5 Small-cap Pharma Stocks of 2025
Aug 12, 2025
5 Biggest Pharmaceutical ETFs in 2025
Jul 24, 2025
Biotech and Pharma Market Update: Q2 2025 in Review
More Featured Articles and Inverviews
Press Releases
Apr 27, 2023
Merck Announces First-Quarter 2023 Financial Results
More Press Releases
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.